Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review

R de Franchis, 2015, Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension, J Hepatol, 63, 743, 10.1016/j.jhep.2015.05.022

J Bosch, 2009, The clinical use of HVPG measurements in chronic liver disease, Nat Rev Gastroenterol Hepatol, 6, 573, 10.1038/nrgastro.2009.149

B Simbrunner, 2019, Gut-liver axis signaling in portal hypertension, World J Gastroenterol, 25, 5897, 10.3748/wjg.v25.i39.5897

M Mandorfer, 2019, Hepatic venous pressure gradient response in non-selective beta-blocker treatment—Is it worth measuring?, Curr Hepatol Rep, 18, 174, 10.1007/s11901-019-00469-x

C Villanueva, 2019, β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 393, 1597, 10.1016/S0140-6736(18)31875-0

M Mandorfer, 2019, Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon-free therapy, Hepatology, 10.1002/hep.30885

A De Gottardi, 2019, Porto-sinusoidal vascular disease: proposal and description of a novel entity, Lancet Gastroenterol Hepatol, 4, 399, 10.1016/S2468-1253(19)30047-0

A Berzigotti, 2011, Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension, Dis Markers, 31, 129, 10.1155/2011/954812

J A Carrión, 2006, Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation, Liver Transpl, 12, 1791, 10.1002/lt.20857

S Y Choi, 2014, Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis, Radiology, 273, 917, 10.1148/radiol.14140008

P Salzl, 2014, Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index, Ultraschall Med, 35, 528, 10.1055/s-0034-1366506

A Colecchia, 2012, Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis, Gastroenterology, 143, 646, 10.1053/j.gastro.2012.05.035

L Annet, 2003, Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension, Radiology, 229, 409, 10.1148/radiol.2292021128

D Thabut, 2007, Relationship between the Fibrotest and portal hypertension in patients with liver disease, Aliment Pharmacol Ther, 26, 359, 10.1111/j.1365-2036.2007.03378.x

T D Sandahl, 2016, The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis, Aliment Pharmacol Ther, 43, 1222, 10.1111/apt.13618

S Hametner, 2016, The VITRO Score (Von Willebrand factor antigen/thrombocyte ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including ELF test, PLoS One, 11, e0149230, 10.1371/journal.pone.0149230

R Paternostro, 2019, Elastography-based screening for esophageal varices in patients with advanced chronic liver disease, World J Gastroenterol, 25, 308, 10.3748/wjg.v25.i3.308

A De Gottardi, 2018, Ultrasonography in liver vascular disease, Ultraschall Med, 39, 382, 10.1055/a-0647-1658

M Y Kim, 2012, Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis, Hepatology, 56, 1053, 10.1002/hep.25752

I Amat-Roldan, 2015, Assessment of hepatic vascular network connectivity with automated graph analysis of dynamic contrast-enhanced US to evaluate portal hypertension in patients with cirrhosis: a pilot study, Radiology, 277, 268, 10.1148/radiol.2015141941

A Berzigotti, 2018, Non-invasive measurement of HVPG using graph analysis of dynamic contrast-enhanced ultrasound: the CLEVER study, J Hepatol, 68, S76, 10.1016/S0168-8278(18)30372-6

J R Eisenbrey, 2013, Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient, Radiology, 268, 581, 10.1148/radiol.13121769

P Schwabl, 2015, New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension, Liver Int, 35, 381, 10.1111/liv.12623

F Vizzutti, 2007, Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis, Hepatology, 45, 1290, 10.1002/hep.21665

T Reiberger, 2012, Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis, J Gastroenterol, 47, 561, 10.1007/s00535-011-0517-4

S Augustin, 2014, Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study, J Hepatol, 60, 561, 10.1016/j.jhep.2013.10.027

C Bureau, 2008, Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease, Aliment Pharmacol Ther, 27, 1261, 10.1111/j.1365-2036.2008.03701.x

J G Abraldes, 2016, Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study, Hepatology, 64, 2173, 10.1002/hep.28824

S Petta, 2018, Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis, J Hepatol, 69, 878, 10.1016/j.jhep.2018.05.019

L Pérez-Latorre, 2014, Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography, Clin Infect Dis, 58, 713, 10.1093/cid/cit768

M T Kitson, 2015, Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications, Scand J Gastroenterol, 50, 462, 10.3109/00365521.2014.964758

M A Robic, 2011, Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study, J Hepatol, 55, 1017, 10.1016/j.jhep.2011.01.051

M Cescon, 2012, Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma, Ann Surg, 256, 706, 10.1097/SLA.0b013e3182724ce8

M Rajakannu, 2017, Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma, Surgery, 162, 766, 10.1016/j.surg.2017.06.006

B Procopet, 2018, Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma, Med Ultrason, 20, 272, 10.11152/mu-1548

F Piecha, 2018, Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome, Am J Physiol Gastrointest Liver Physiol, 315, G484, 10.1152/ajpgi.00392.2017

C H Suh, 2018, Shear wave elastography as a quantitative biomarker of clinically significant portal hypertension: a systematic review and meta-analysis, AJR Am J Roentgenol, 210, W185, 10.2214/AJR.17.18367

L Elkrief, 2015, Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis, Radiology, 275, 589, 10.1148/radiol.14141210

B Procopet, 2015, Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension, J Hepatol, 62, 1068, 10.1016/j.jhep.2014.12.007

T Y Kim, 2015, Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients, Liver Int, 35, 2416, 10.1111/liv.12846

C Jansen, 2017, Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: a prospective multicentre study, Liver Int, 37, 396, 10.1111/liv.13243

L Elkrief, 2018, Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis, Aliment Pharmacol Ther, 47, 621, 10.1111/apt.14488

D Attia, 2015, Evaluation of liver and spleen stiffness with acoustic radiation force impulse quantification elastography for diagnosing clinically significant portal hypertension, Ultraschall Med, 36, 603, 10.1055/s-0041-107971

Y Shen, 2017, Liver stiffness assessed by shear wave elastography predicts postoperative liver failure in patients with hepatocellular carcinoma, J Gastrointest Surg, 21, 1471, 10.1007/s11605-017-3443-9

D Wu, 2017, Predicting the risk of postoperative liver failure and overall survival using liver and spleen stiffness measurements in patients with hepatocellular carcinoma, Medicine (Baltimore), 96, e7864, 10.1097/MD.0000000000007864

J G Lee, 2020, Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis, Korean J Intern Med (Korean Assoc Intern Med), 35, 88

C Jansen, 2018, Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality, Hepatology, 67, 1472, 10.1002/hep.29612

A Berzigotti, 2017, Non-invasive evaluation of portal hypertension using ultrasound elastography, J Hepatol, 67, 399, 10.1016/j.jhep.2017.02.003

M Buechter, 2018, Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation, Dig Liver Dis, 50, 54, 10.1016/j.dld.2017.09.138

Y Takuma, 2016, Portal hypertension in patients with liver cirrhosis: diagnostic accuracy of spleen stiffness, Radiology, 279, 609, 10.1148/radiol.2015150690

A Colecchia, 2014, Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study, J Hepatol, 60, 1158, 10.1016/j.jhep.2014.02.024

Y Takuma, 2017, Measurement of spleen stiffness with acoustic radiation force impulse imaging predicts mortality and hepatic decompensation in patients with liver cirrhosis, Clin Gastroenterol Hepatol, 15, 1782, 10.1016/j.cgh.2016.10.041

W Peng, 2019, Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma, Medicine (Baltimore), 98, e15458, 10.1097/MD.0000000000015458

G Marasco, 2019, Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection, J Hepatol, 70, 440, 10.1016/j.jhep.2018.10.022

H Gouya, 2016, Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging, Eur Radiol, 26, 1981, 10.1007/s00330-015-3991-x

J Bosch, 1984, Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis, Hepatology, 4, 424, 10.1002/hep.1840040312

J Bosch, 1984, Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis, Hepatology, 4, 1200, 10.1002/hep.1840040617

U Motosugi, 2019, Four-dimensional flow MRI as a marker for risk stratification of gastroesophageal varices in patients with liver cirrhosis, Radiology, 290, 101, 10.1148/radiol.2018180230

M Ronot, 2014, Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis, Eur Radiol, 24, 1394

A M Gharib, 2017, Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease, BioMed Res Int, 2017, 2067479, 10.1155/2017/2067479

M Wagner, 2018, Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: preliminary results, J Magn Reson Imaging, 48, 1091, 10.1002/jmri.26026

U Asenbaum, 2017, Effects of portal hypertension on gadoxetic acid-enhanced liver magnetic resonance: diagnostic and prognostic implications, Invest Radiol, 52, 462, 10.1097/RLI.0000000000000366

M Haimerl, 2017, Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: comparison between signal-intensity-based indices and T1 relaxometry, Sci Rep, 7, 43347, 10.1038/srep43347

M Haimerl, 2018, Hepatobiliary MRI: SIGNAL intensity based assessment of liver function correlated to 13C-methacetin breath test, Sci Rep, 8, 9078, 10.1038/s41598-018-27401-5

C Levick, 2019, Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: a proof of concept study, PLoS One, 14, e0221066, 10.1371/journal.pone.0221066

N Palaniyappan, 2016, Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging, J Hepatol, 65, 1131, 10.1016/j.jhep.2016.07.021

S K Asrani, 2014, Role of magnetic resonance elastography in compensated and decompensated liver disease, J Hepatol, 60, 934, 10.1016/j.jhep.2013.12.016

N Bastati, 2020, Does the functional liver imaging score derived from gadoxetic acid-enhanced MRI predict outcomes in chronic liver disease?, Radiology, 294, 98, 10.1148/radiol.2019190734

C R Bradley, 2018, Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging, J Hepatol, 69, 1015, 10.1016/j.jhep.2018.05.037

A Lisotti, 2014, Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis, Hepatology, 59, 643, 10.1002/hep.26700

S Møller, 2019, Indocyanine green retention test in cirrhosis and portal hypertension: accuracy and relation to severity of disease, J Gastroenterol Hepatol, 34, 1093, 10.1111/jgh.14470

M L Pind, 2016, Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis, Eur J Gastroenterol Hepatol, 28, 948, 10.1097/MEG.0000000000000611

A Lisotti, 2016, Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension, Liver Int, 36, 1313, 10.1111/liv.13070

C Schwarz, 2019, The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection, Sci Rep, 9, 8421, 10.1038/s41598-019-44815-x

A Berzigotti, 2013, Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis, Gastroenterology, 144, 102, 10.1053/j.gastro.2012.10.001

A Berzigotti, 2008, Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis, Am J Gastroenterol, 103, 1159, 10.1111/j.1572-0241.2008.01826.x

S H Park, 2009, Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis, J Gastroenterol Hepatol, 24, 1289, 10.1111/j.1440-1746.2009.05904.x

V Verma, 2014, Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis, United European Gastroenterol J, 2, 226, 10.1177/2050640614527084

E J Cho, 2015, Diagnostic and prognostic values of noninvasive predictors of portal hypertension in patients with alcoholic cirrhosis, PLoS One, 10, e0133935, 10.1371/journal.pone.0133935

B Procopet, 2015, Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension, Dig Liver Dis, 47, 411, 10.1016/j.dld.2015.02.001

L Wang, 2017, Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis, PLoS One, 12, e0182969, 10.1371/journal.pone.0182969

V Kirnake, 2018, Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis, Indian J Gastroenterol, 37, 335, 10.1007/s12664-018-0879-0

A M Gressner, 1986, Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease, Klin Wochenschr, 64, 1240, 10.1007/BF01734467

A M Gressner, 1986, Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases, Clin Chim Acta, 161, 249, 10.1016/0009-8981(86)90008-2

M Kondo, 1995, The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels, Hepatogastroenterology, 42, 542

J Kropf, 1991, Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum, Clin Chem, 37, 30, 10.1093/clinchem/37.1.30

T M Busk, 2014, TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes, Scand J Gastroenterol, 49, 1103, 10.3109/00365521.2014.934910

J Bosch, 2015, Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments, J Hepatol, 62, S121, 10.1016/j.jhep.2015.01.003

H Grønbaek, 2012, Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis, Aliment Pharmacol Ther, 36, 173, 10.1111/j.1365-2036.2012.05134.x

M Ferlitsch, 2012, von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis, Hepatology, 56, 1439, 10.1002/hep.25806

V La Mura, 2011, Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension, Gut, 60, 1133, 10.1136/gut.2010.235689

M Mandorfer, 2018, Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity, Aliment Pharmacol Ther, 47, 980, 10.1111/apt.14522

R Schwarzer, 2019, The von Willebrand factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis, J Gastroenterol, 10.1007/s00535-019-01656-9

G P Györi, 2019, Von Willebrand factor facilitates MELD-independent risk stratification on the waiting list for liver transplantation, Hepatology, 10.1002/hep.31047

A Bhardwaj, 2017, Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial, Gut, 66, 1838, 10.1136/gutjnl-2016-311735

M Mandorfer, 2017, Prevention of progression from small to large varices: are we there yet? An updated meta-analysis, Gut, 66, 1347, 10.1136/gutjnl-2016-312814

J Bruix, 1996, Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure, Gastroenterology, 111, 1018, 10.1016/S0016-5085(96)70070-7

E Llop, 2012, Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors, J Hepatol, 56, 103, 10.1016/j.jhep.2011.06.027

E Boleslawski, 2012, Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis, Br J Surg, 99, 855, 10.1002/bjs.8753

A Cucchetti, 2016, Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma, J Hepatol, 64, 79, 10.1016/j.jhep.2015.08.025

A Berzigotti, 2015, Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis, Hepatology, 61, 526, 10.1002/hep.27431

European Association for the Study of the Liver, 2018, EASL clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, 69, 182, 10.1016/j.jhep.2018.03.019

F Piecha, 2016, Arterial pressure suffices to increase liver stiffness, Am J Physiol Gastrointest Liver Physiol, 311, G945, 10.1152/ajpgi.00399.2015

Y Zhu, 2019, Portal hypertension in hepatitis B-related cirrhosis: diagnostic accuracy of liver and spleen stiffness by 2-D shear-wave elastography, Hepatol Res, 49, 540, 10.1111/hepr.13306

H Y Kim, 2019, Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices, J Hepatol, 70, 412, 10.1016/j.jhep.2018.10.018

T Reiberger, 2013, Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol, Gut, 62, 1634, 10.1136/gutjnl-2012-304038

M Mandorfer, 2017, Beta blockers and cirrhosis, 2016, Dig Liver Dis, 49, 3, 10.1016/j.dld.2016.09.013

T Reiberger, 2017, Beta adrenergic blockade and decompensated cirrhosis, J Hepatol, 66, 849, 10.1016/j.jhep.2016.11.001

J Trebicka, 2016, Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients, J Hepatol, 64, 1265, 10.1016/j.jhep.2016.01.022

E Reverter, 2019, Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis, Liver Int, 39, 705, 10.1111/liv.14042

T Reiberger, 2017, Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III), Wien Klin Wochenschr, 129, 135, 10.1007/s00508-017-1262-3

M Mandorfer, 2016, Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension, J Hepatol, 65, 692, 10.1016/j.jhep.2016.05.027

S Lens, 2017, Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis, Gastroenterology, 153, 1273, 10.1053/j.gastro.2017.07.016

M Mandorfer, 2018, Monitoring the evolution of portal hypertension after sustained virologic response, Gastroenterology, 154, 1550, 10.1053/j.gastro.2017.08.078

V Knop, 2016, Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy, J Viral Hepat, 23, 994, 10.1111/jvh.12578

M Pons, 2017, Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals, Therap Adv Gastroenterol, 10, 619, 10.1177/1756283X17715198

M Pons, 2019, Non-invasive prediction of liver related events in HCV compensated advanced chronic liver disease patients after oral antivirals, J Hepatol, 10.1016/j.jhep.2019.10.005

F Conti, 2016, Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals, J Hepatol, 65, 727, 10.1016/j.jhep.2016.06.015

E Degasperi, 2019, Factors associated with increased risk of de novo or recurrent hepatocellular carcinoma in patients with cirrhosis treated with direct-acting antivirals for HCV infection, Clin Gastroenterol Hepatol, 17, 1183, 10.1016/j.cgh.2018.10.038

F Ravaioli, 2018, Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals, Dig Liver Dis, 50, 573, 10.1016/j.dld.2018.02.010

P Schwabl, 2017, Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease, Aliment Pharmacol Ther, 45, 139, 10.1111/apt.13844

F Ravaioli, 2018, Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients, World J Hepatol, 10, 731, 10.4254/wjh.v10.i10.731

L Haider, 2018, Noninvasive monitoring of liver disease regression after hepatitis C eradication using gadoxetic acid-enhanced MRI, Contrast Media Mol Imaging, 2018, 8489709, 10.1155/2018/8489709

C Bradley, 2019, Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients, Eur Radiol, 29, 3100, 10.1007/s00330-018-5788-1

S Wu, 2018, On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis, Liver Int, 38, 1045, 10.1111/liv.13623

S Seijo, 2012, Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension, Dig Liver Dis, 44, 855, 10.1016/j.dld.2012.05.005

P Sharma, 2017, Transient elastography (Fibroscan) in patients with non-cirrhotic portal fibrosis, J Clin Exp Hepatol, 7, 230, 10.1016/j.jceh.2017.03.002

R Vuppalanchi, 2018, Liver stiffness measurements in patients with noncirrhotic portal hypertension—the devil is in the details, Hepatology, 68, 2438, 10.1002/hep.30167

P Sharma, 2012, Liver and spleen stiffness in patients with extrahepatic portal vein obstruction, Radiology, 263, 893, 10.1148/radiol.12111046

K S Madhusudhan, 2018, Measurement of splenic stiffness by 2D-shear wave elastography in patients with extrahepatic portal vein obstruction, Br J Radiol, 91, 20180401, 10.1259/bjr.20180401

K S Madhusudhan, 2018, Evaluation of splenic stiffness in patients of extrahepatic portal vein obstruction using 2D shear wave elastography: comparison with intra-operative portal pressure, J Clin Exp Hepatol, 8, 250, 10.1016/j.jceh.2017.12.002

Y Furuichi, 2013, Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography, J Gastroenterol, 48, 1061, 10.1007/s00535-012-0703-z

European Association for the Study of the Liver, 2016, EASL Clinical Practice Guidelines: Vascular diseases of the liver, J Hepatol, 64, 179, 10.1016/j.jhep.2015.07.040

A Colecchia, 2019, Liver stiffness measurement allows early diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study, Biol Blood Marrow Transplant, 25, 995, 10.1016/j.bbmt.2019.01.019

M Mohty, 2016, Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation, Bone Marrow Transplant, 51, 906, 10.1038/bmt.2016.130

F Ravaioli, 2019, Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review, Expert Rev Gastroenterol Hepatol, 13, 463, 10.1080/17474124.2019.1588111

P G Richardson, 2017, Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation, Br J Haematol, 178, 112, 10.1111/bjh.14727

A Mukund, 2017, Changes in liver congestion in patients with Budd-Chiari syndrome following endovascular interventions: assessment with transient elastography, J Vasc Interv Radiol, 28, 683, 10.1016/j.jvir.2016.11.091

H W Wang, 2018, Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: a pilot study, PLoS One, 13, e0197550, 10.1371/journal.pone.0197550

E Dajti, 2019, Liver and spleen stiffness measurements for assessment of portal hypertension severity in patients with Budd Chiari syndrome, Can J Gastroenterol Hepatol, 2019, 1673197, 10.1155/2019/1673197

P Xu, 2019, Segmental liver stiffness evaluated with magnetic resonance elastography is responsive to endovascular intervention in patients with Budd-Chiari syndrome, Korean J Radiol, 20, 773, 10.3348/kjr.2018.0767